Myeloma

Recognized by U.S. News & World Report

UT Southwestern Medical Center's treatment of leukemia, lymphoma, and myeloma is rated as "High Performing" by U.S. News & World Report, placing us among the nation’s top hospitals for this area of care.

At UT Southwestern Medical Center, our experts specialize in treatment for every stage of myeloma. We offer patients access to the most innovative therapies and a range of clinical trials that aren’t available at every hospital. 

As the only National Cancer Institute-designated comprehensive cancer center in North Texas, we deliver the best cancer care available today and push to discover new treatments. NCI designation means we offer patients the ability to participate in the broadest possible range of clinical trials, with access to potential therapies not available at other facilities.

Unmatched Expertise and Compassionate Care for Myeloma

Myeloma is a bone marrow cancer that starts in the plasma cells. Plasma cells are white blood cells that are part of the immune system. When plasma cells become malignant, they affect healthy blood cell production, which weakens the immune system. If left untreated, the cancerous cells can lead to kidney damage and bone destruction. 

More than 90 percent of patients diagnosed with myeloma have multiple myeloma, which means that the cancerous cells, known as myeloma cells once they are malignant, have developed in more than one location in the bone marrow. 

While myeloma is not curable, it is treatable, especially at a top cancer center like UT Southwestern that has the newest therapies. 

For patients with myeloma, we offer:

• Myeloma expertise that is unmatched in Dallas-Ft. Worth
• Access to cutting-edge treatments and clinical trial research for every stage of myeloma
• Bone marrow transplant and nontransplant treatment modalities
• Opportunity for one physician to handle all-of-a patient’s care, from diagnosis to transplant and beyond
• State-of-the-art, 32-bed hospital unit built specifically for immunocompromised patients
• A broad range of support services that provide care beyond treatment, for both our patients and their families 

As a new member of the elite Multiple Myeloma Research Foundation, we have access to even more new treatments earlier than other facilities, and we are supporting the continued advancement of myeloma therapies. At any time, we have eight to 10 myeloma clinical trials available to our patients.

Every Treatment at Every Stage

Whether patients are newly diagnosed or experiencing a relapse, we offer the most advanced therapies and the experience and compassion they deserve in their fight against this disease. 

We welcome referrals from other doctors whose patients need bone marrow transplants. We will coordinate with referring physicians, perform the transplant, and refer patients back once they have recovered from the transplant.